Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00245856 · ClinicalTrials.gov registry record · Phase 4
Treatment of Upper Extremity Deep-Vein Thrombosis
A Phase 4 study, sponsored by University of Oklahoma.
- Completed
- Registry status
- Phase 4
- Development phase
- 67
- Enrollment target
NCT00245856: Completed Phase 4 study, sponsored by University of Oklahoma.
NCT00245856 is a Phase 4 study that has completed, run by University of Oklahoma. The registered enrollment target is 67 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00245856, a Phase 4 study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to document the long-term outcome or prognosis of patients diagnosed with upper extremity deep-vein thrombosis who are treated with Fragmin (dalteparin sodium injection) for three months.
Interventions
- DRUG Warfarin
- DRUG Dalteparin sodium injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2002-09 |
| Est. Completion | 2011-12 |
| Phase | Phase 4 |
What the finished NCT00245856 record still lists
NCT00245856 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Warfarin is the first listed.
NCT00245856 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00245856 about?
NCT00245856 is a clinical study titled "Treatment of Upper Extremity Deep-Vein Thrombosis". The purpose of this study is to document the long-term outcome or prognosis of patients diagnosed with upper extremity deep-vein thrombosis who are treated with Fragmin (dalteparin sodium injection) for three months.
What is the current status of trial NCT00245856?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 67 participants. The study started on 2002-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00245856?
The interventions under investigation include: Warfarin (DRUG), Dalteparin sodium injection (DRUG).
Who is sponsoring clinical trial NCT00245856?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00245856's enrollment target sits among peer trials
67 1083rd of 2000 higher than 918 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia